Guillain–Barré syndrome (GBS) is a potentially life-threatening postinfectious disease
characterized by rapidly progressive, symmetrical weakness of the extremities. About 25% of …

Guillain-Barré syndrome is the most common and most severe acute paralytic neuropathy,
with about 100 000 people developing the disorder every year worldwide. Under the …

Guillain-Barré syndrome (GBS) is an important cause of acute neuromuscular paralysis.
Molecular mimicry and a cross-reactive immune response play a crucial part in its …

Guillain–Barré syndrome (GBS) is a rare, but potentially fatal, immune-mediated disease of
the peripheral nerves and nerve roots that is usually triggered by infections. The incidence of …

Molecular mimicry between microbial antigens and host tissue forms an attractive
hypothetical mechanism for the triggering of autoimmune disease by preceding infections …

Summary Background Guillain-Barré syndrome (GBS) is an acute post-infectious immune-
mediated peripheral neuropathy with a highly variable clinical course and outcome. We …

Guillain-Barré syndrome is a heterogeneous disorder regarding the clinical presentation,
electrophysiological subtype and outcome. Previous single country reports indicate that …

Objective Respiratory insufficiency is a frequent and serious complication of the Guillain‐
Barré syndrome (GBS). We aimed to develop a simple but accurate model to predict the …

The group of patients with Guillain‐Barré syndrome (GBS) is very heterogenous with regard
to antecedent infections, immunological parameters, clinical manifestations, and response to …

Molecular mimicry of Campylobacter jejuni lipo-oligosaccharides (LOS) with gangliosides in
nervous tissue is considered to induce cross-reactive antibodies that lead to Guillain-Barré …